Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extension Study of JTT-751 in Non-dialysis CKD Patients
jRCT2080221399Phase 3
- Sponsor
- Japan Tobacco
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of ferric citrate in chronic kidney disease (CKD), sponsored by Japan Tobacco.
02
Drugs
ferric citrate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2080221399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221399.